A randomized clinical trial involving 911 asymptomatic individuals in South Korea assessed the role of an artificial intelligence (AI) tool in interpreting low-dose chest computed tomography (LDCT). While the AI tool led to a significant increase in the detection of lung nodules—17% of scans identified positive nodules via AI compared to 10% without it—no notable reduction in interpretation time was observed between the two groups. The study indicates enhanced detection rates without a corresponding impact on lung cancer diagnosis or interpretation efficiency. Source: American Journal of Roentgenology